This study aims to create a tumor heterogeneity-based model for predicting the best features of 5 lung adenocarcinoma (LUAD) in multiple cancer subtypes using the Least Absolute Shrinking 6 and Selection Operator (LASSO). The RNA-Seq raw count data of 533 LUAD samples and 59 7 normal samples were downloaded from the TCGA data portal. Based on consensus clustering 8 method samples was divided into two subtypes, and clusters were validated using silhouette 9 width. Furthermore, we estimated subtypes for the abundance of immune and non-immune 1 6
1 0 stromal cell populations which infiltrated cancer tissue. We established the LASSO model for 1 1 predicting each subtype's best features. Enrichment pathway analysis was then carried out. We used Consensus clustering (CC) method, an unsupervised clustering method for grouping 1 0 3 subtypes in LUAD. CC method is the most widely used for subtype discovery in high 1 0 4 dimensional datasets. We used settings of the agglomerative hierarchical clustering algorithm 1 0 5 using Pearson correlation distance. Two distinct clusters were discovered in our datasets, 89 and 1 0 6 444 samples were clustered in Subtype-1 and Subtype-2 respectively (Fig.1.A) . We have 1 0 7 validated consistency within clusters of data using Silhouette width ( Fig.1.B ). 
Identification of DEGs in Subtype-1 and Subtype-2 LUAD samples.
1 1 2 upregulated, and 1219 were downregulated in case of subtype-2 ( Fig.2 .B) shows differential 1 1 3 expression pattern in subtype-1 and subtype-2. The DEGs in both subtypes were used for 1 1 4
building the LASSO predictive model and for the identification of best predictor genes in LUAD with smaller sample size and a large number of features also called small-n-large-p datasets (p 1 2 0 >> n). High dimensional data will be sparse, and only a few features affect the response variable, 1 2 1 and LASSO is known to identify the best features that affect the response variable. We deal with 1 2 2 a p >> n situation for feature selection in our Subtype-1 and Subtype-2 datasets, thus probably The purpose of our analysis is to identify the feature selection task and underline which genes are 1 2 5 more relevant to predict and to classify them as biomarkers, to do so, we have used the LASSO 1 2 6 model. The result shows the trends of the 40 and 43 most relevant features selected by our model in subtype-1 and subtype-2 LUAD, respectively. The next step would be to find the most 1 2 9 appropriate values for λ for our LASSO model. We analysed the λ value using the 10 fold cross- model such that error is within one standard error of the minimum. Using this analysis, we 1 3 2 obtained the most relevant genes which are unique to subtype-1 and subtype-2 in the detection of 1 3 3 a LUAD. A list of best-predicted genes available for each cancer subtypes is shown in Table 1 . The abundance of tissue-infiltrating immune and non-immune stromal cell populations is highly 1 3 6 informative. It has been shown that the extent of infiltrating immune cells is associated with Subtype-1 and Subtype-2 showed distinct and unique features which are involved in cancer 1 5 1 progression. Genes such as IL22RA2, PLA2G2C identified in subtype1 are upregulated and 1 5 2 found to be involved in canonical cancer regulatory pathways such as the JAK-STAT signalling 1 5 3 pathway and RAS signalling pathway (Fig. 4) . The PLA2G2C gene is associated with alpha- Linolenic acid as well as ether lipid metabolism, and both are known to play a role in cancer regulating pluripotency of stem cells and DEFA3 gene which is associated with Transcriptional 1 5 7 misregulation in cancer. The gene AWAT2 identified in subtype1 is found to be involved in 1 5 8
Retinol metabolism, and studies suggest that retinoid signalling triggers tumor development [17] .
The NECTIN4 gene highlighted in our study is associated with Adherens junction, which plays 1 6 0 an essential role in cancer initiation and progression [18] . PYCR1 gene involved in proline 1 6 1 metabolism which is highly correlated with cancer is also found to be differentially expressed in 1 6 2 subtype1. EFNA3 is upregulated in Subtype-2, and previous studies show that it contributes to 1 6 3 the metastatic spread of breast cancer [19] . Our model predicted that increased expression of 1 6 4
LGR4, TESC, TOP2A, and ZNF695 is suggestive of increased invasive and metastatic activity in The LUAD samples were classified into two subtypes based on the consensus clustering method. Overall survival analysis for the most predictive genes identified by our model in Subtype-1 and 1 7 0 Subtype-2 groups was conducted. The genes predicted by our LASSO model accurately predictions for the risk of LUAD and can be used in cancer prediction. Survival plots and its p- In this study, we developed a LASSO based model for accurate feature selection in LUAD. Our information in disease prediction. Analysis using the survival data for the predicted genes showed that the model could effectively predict genes responsible for disease prognosis in high 1 8 0 dimensional datasets. Deciphering cancer heterogeneity is very critical in understanding cancer 1 8 1 dynamics and also for the development of personalised cancer treatment [22] . We used 1 8 2
Discussion
Consensus clustering method to determine the number of clusters in our samples, and we 1 8 3 clustered the samples into two groups which produced optimal silhouette width for the 1 8 4 determined clusters. Differential gene expression analysis showed distinct expression patterns in The number of differentially expressed genes was very high, and in these situations, it is difficult and STX11 in Subtype-2 showed worse overall survival in LUAD samples. Whereas increased 1 9 2 expression of genes such as CDC37P2, DCST1, IL22RA2, LAD1, NECTIN4, SLC25A48, 1 9 3 TMEM51.AS1, TMPRSS4, VPS9D1-AS1, AWAT2, BCL9P1 and CD5L in Subtype-1 and 1 9 4 EFNA3, LGR4, TESC, TOP2A and ZNF695 in subtype-2 showed decreased overall survival in 1 9 5 LUAD samples. Long intervening noncoding RNAs (lncRNAs) are known to be critical regulators of numerous 1 9 7 biological processes, and substantial evidence supports that lncRNA expression plays a 1 9 8 significant role in tumorigenesis and tumor progression. Increased expression of LINC00862 in The best predictors for subtype-1 and subtype-2 from the LASSO model were found to be 2 0 5 involved in several regulatory pathways. Subtype-1 gene such as S100A12 is a vital serum 2 0 6 inflammatory marker and has been illustrated in several cancer types such as oropharyngeal Various studies indicate the role of STX11 expression in suppressing the proliferation of T-cell Our model predicts lncRNAs such as LINC01506, LINC01785, LINC01996, LINC00862, and 2 2 5 LINC02014 were expressed in subtype-1 and subtype-2 samples which can be considered as 2 2 6 potential biomarkers and shows poor overall survival in LUAD. LncRNAs might be used as 2 2 7 biomarkers and drug targets for early diagnosis, prognosis and personalised treatment of LUAD 2 2 8 patients.
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Our study suggests that Consensus Clustering methods and LASSO combined will help us to 2 3 0 develop a model with the most appropriate characteristics. Consistent with these finding, the Subtypes, indicating that LASSO model could effectively be used to overcome the feature 2 3 5 selection problem and can be used for accurate prediction of risk in LUAD. Funding: This research did not receive any specific grant from funding agencies in the public, 2 3 8 commercial, or not-for-profit sectors. Fig.4. Fig.4. Pathway analysis for the best predicted genes by LASSO model. (A) Subtype-1 
